This was reported to Interfax by the head of the Gamaleya Center of the Ministry of Health of Russia, Academician of the Russian Academy of Sciences Alexander Gintsburg.
“Tests are going well.
The need to shorten the duration of clinical trials of the intranasal form of the vaccine is now being very intensively discussed in order to introduce this drug into civilian circulation as quickly as possible, which, everyone hopes, will reduce infection and transmission of the coronavirus,” Gunzburg said.
Earlier, Gunzburg said that the nasal vaccine against COVID-19 will be two-component.
Vladislav Zhemchugov, Doctor of Medical Sciences, an immunologist, a specialist in especially dangerous infections, in an interview with Komsomolskaya Pravda radio spoke about three possible ways for the further development of the situation with coronavirus.